Mark Kelly is an experienced business development professional with a strong background in the biotechnology and biopharmaceutical industries. They have over nine years of scientific research experience, particularly in molecular and cell biology, covering areas such as pharmacology, immunology, and reproductive biology. Mark has held several roles, including Business Development Manager at Charles River Laboratories and Synexa Life Sciences, and most recently serves as Senior Business Development Director at Labcorp. They also completed a research associate position at the University of Dundee and are currently pursuing a PhD in Renal Physiology and Pharmacology at the University of Kent.
This person is not in any teams
This person is not in any offices